KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $250,000 | -34.2% | 17,236 | -55.4% | 0.03% | -42.1% |
Q2 2022 | $380,000 | +9.8% | 38,650 | +64.5% | 0.06% | +23.9% |
Q1 2022 | $346,000 | +127.6% | 23,502 | +104.4% | 0.05% | +142.1% |
Q4 2021 | $152,000 | -64.7% | 11,499 | -49.3% | 0.02% | -72.9% |
Q4 2020 | $430,000 | +34.0% | 22,664 | -11.0% | 0.07% | +29.6% |
Q3 2020 | $321,000 | +150.8% | 25,466 | +51.7% | 0.05% | +68.8% |
Q1 2020 | $128,000 | -57.3% | 16,786 | -0.3% | 0.03% | -8.6% |
Q4 2019 | $300,000 | +150.0% | 16,836 | +63.1% | 0.04% | +118.8% |
Q3 2019 | $120,000 | -43.1% | 10,321 | +40.0% | 0.02% | -23.8% |
Q1 2019 | $211,000 | – | 7,371 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Saturn V Capital Management LP | 719,937 | $6,697,459 | 5.56% |
TCG Crossover Management, LLC | 3,395,495 | $22,953,546 | 4.05% |
VR Adviser, LLC | 2,916,667 | $19,716,669 | 3.32% |
TANG CAPITAL MANAGEMENT LLC | 3,196,446 | $21,607,975 | 3.14% |
Prosight Management, LP | 621,667 | $4,202,469 | 2.29% |
Opaleye Management Inc. | 923,200 | $6,240,832 | 2.17% |
GREAT POINT PARTNERS LLC | 1,055,801 | $7,137,215 | 1.40% |
Frazier Life Sciences Management, L.P. | 3,238,859 | $21,894,687 | 1.36% |
DAFNA Capital Management LLC | 616,032 | $4,164,376 | 1.17% |
Vivo Capital, LLC | 856,008 | $5,787 | 0.67% |